NEUMORA THERAPEUTICS INC(NASDAQ:NMRA) stock News

NMRA Latest News, Press Relases and Analysis

All

Press Releases

8 days ago - By: Neumora Therapeutics, Inc.

Neumora Therapeutics to Participate in Upcoming Conferences in September

8 days ago - By: Neumora Therapeutics, Inc.

Neumora Therapeutics to Participate in Upcoming Conferences in September

a month ago - By: The Motley Fool

Neumora (NMRA) Q2 Loss Improves 10%

a month ago - By: Neumora Therapeutics, Inc.

Neumora Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

a month ago - By: Neumora Therapeutics, Inc.

Neumora Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

a month ago - By: Benzinga - Mentions: OEC VTLE DIN INSE ...

Earnings Scheduled For August 6, 2025

a month ago - By: Yahoo Finance

Mizuho Raises Price Target for Neumora (NMRA), Keeps Outperform Rating

a month ago - By: Benzinga - Mentions: EXEL MLSS PTCT ADAP ...

12 Health Care Stocks Moving In Monday's After-Market Session

2 months ago - By: Neumora Therapeutics, Inc.

Neumora Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025

2 months ago - By: Neumora Therapeutics, Inc.

Neumora Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025

2 months ago - By: Yahoo Finance

Mizuho Lifts PT on Neumora Therapeutics (NMRA) to $5 from $4, Keeps Outperform Rating

2 months ago - By: Neumora Therapeutics, Inc.

Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861

2 months ago - By: Neumora Therapeutics, Inc.

Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861

4 months ago - By: Kuehn Law, PLLC

Kuehn Law Encourages Investors of Neumora Therapeutics, Inc. to Contact Law Firm

4 months ago - By: Neumora Therapeutics, Inc.

Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

4 months ago - By: Neumora Therapeutics, Inc.

Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

4 months ago - By: Neumora Therapeutics, Inc.

Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

5 months ago - By: The Schall Law Firm

NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

5 months ago - By: The Gross Law Firm

Neumora Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 7, 2025 to Discuss Your Rights - NMRA

5 months ago - By: Faruqi & Faruqi LLP

Faruqi & Faruqi Reminds Neumora Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - NMRA

5 months ago - By: Kessler Topaz Meltzer & Check, LLP

NMRA Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Neumora Therapeutics, Inc. (NMRA) Investors of Filing Deadline in Class Action Lawsuit

5 months ago - By: Levi & Korsinsky, LLP

Levi & Korsinsky Reminds Neumora Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - NMRA

5 months ago - By: Faruqi & Faruqi, LLP

NMRA Investors Have Opportunity to Lead Neumora Therapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

5 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Neumora Therapeutics, Inc of Class Action Lawsuit and Upcoming Deadlines - NMRA

5 months ago - By: The Gross Law Firm

Shareholders of Neumora Therapeutics, Inc. Should Contact The Gross Law Firm Before April 7, 2025 to Discuss Your Rights - NMRA

5 months ago - By: Faruqi & Faruqi LLP

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

5 months ago - By: Bernstein Liebhard LLP

NEUMORA THERAPEUTICS INC (NMRA) Stock News

NMRA Latest News, Press Relases and Analysis

Neumora Therapeutics to Participate in Upcoming Conferences in September

Neumora Therapeutics to Participate in Upcoming Conferences in September

Neumora (NMRA) Q2 Loss Improves 10%

Neumora Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Neumora Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Earnings Scheduled For August 6, 2025

Mizuho Raises Price Target for Neumora (NMRA), Keeps Outperform Rating

12 Health Care Stocks Moving In Monday's After-Market Session

Neumora Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025

Neumora Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025

Mizuho Lifts PT on Neumora Therapeutics (NMRA) to $5 from $4, Keeps Outperform Rating

Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861

Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861

Kuehn Law Encourages Investors of Neumora Therapeutics, Inc. to Contact Law Firm

Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Neumora Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 7, 2025 to Discuss Your Rights - NMRA

Faruqi & Faruqi Reminds Neumora Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - NMRA

NMRA Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Neumora Therapeutics, Inc. (NMRA) Investors of Filing Deadline in Class Action Lawsuit

Levi & Korsinsky Reminds Neumora Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - NMRA

NMRA Investors Have Opportunity to Lead Neumora Therapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Neumora Therapeutics, Inc of Class Action Lawsuit and Upcoming Deadlines - NMRA

Shareholders of Neumora Therapeutics, Inc. Should Contact The Gross Law Firm Before April 7, 2025 to Discuss Your Rights - NMRA

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

NEUMORA THERAPEUTICS, INC. (NASDAQ: NMRA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Neumora Therapeutics, Inc. Investors of Upcoming Deadline